Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities

Area of Science:

• Immunology
• Infectious Diseases
• Regenerative Medicine

Background:

• Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), infects a third of the global population.
• TB pathogenesis remains incompletely understood, hindering effective drug development and treatment.
• Mesenchymal stem cells (MSCs) possess immunomodulatory properties, attracting research interest.

Purpose of the Study:

• To review the intricate relationship between MSCs and TB occurrence and progression.
• To explore the potential of MSCs as a novel therapeutic approach for TB treatment.
• To synthesize current research on MSCs in the context of Mtb infection.

Main Methods:

• Literature review of studies investigating MSCs and TB.
• Analysis of research data on MSC-Mtb interactions.
• Synthesis of findings on MSC immunomodulation in TB models.

Main Results:

• Evidence suggests MSCs influence Mtb growth and TB development.
• MSCs demonstrate potential in modulating the immune response during TB infection.
• Current research indicates a significant link between MSCs and TB pathogenesis.

Conclusions:

• MSCs represent a promising avenue for innovative TB treatment strategies.
• Further research into MSC-based therapies could address unmet needs in TB clinical management.
• Understanding MSCs' role is crucial for advancing TB control efforts.